Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 21, 2011; 17(39): 4349-4364
Published online Oct 21, 2011. doi: 10.3748/wjg.v17.i39.4349
Published online Oct 21, 2011. doi: 10.3748/wjg.v17.i39.4349
Table 1 Epidemiological and clinical characteristics of patients in the 18 retrospective studies involving patients with a benign cystic duodenal wall
Author[Ref.] yr | Time interval of | n (%) | Age (yr) | Alcohol drinkers | ||
patient enrollment | Total | Males | Females | Mean (range) | n (%) | |
Stolte et al[7] 1982 | NR | 30 | 30 (100) | - | 41.3 (NR) | 22 (73.3) |
Yamaguchi et al[10] 1992 | 1983-1989 | 8 | 8 (100) | - | 58.0 (33-70) | 4 (50.0) |
Fléjou et al[11] 1993 | 1959-1991 | 10 | 10 (100) | - | 41.0 (31-56) | 2 (20.0) |
Itoh et al[12] 1994 | NR | 4 | 3 (75.0) | 1 (25.0) | 43.0 (37-53) | NR |
Fékété et al[13] 1996 | 1989-1993 | 6 | 6 (100) | - | 40.0 (35-46) | 4 (66.7) |
Procacci et al[16] 1997 | 1992-1996 | 10 | 10 (100) | - | 41.0 (32-59) | 9 (90.0) |
Irie et al[18] 1998 | 1995-1996 | 5 | 5 (100) | - | 41.0 (33-46) | 2 (40.0) |
Vullierme et al[23] 2000 | 1988-1998 | 20 | 18 (90.0) | 2 (10.0) | 44.0 (36-56) | NR |
Aoun et al[81] 2005 | NR | 4 | 2 (50.0) | 2 (50.0) | 69.0 (66-71) | NR |
Pessaux et al[36] 2006 | 1990-2004 | 12 | 11 (91.7) | 1 (8.3) | 42.4 (34-54) | 9 (75.0) |
Jouannaud et al[37] 2006 | 1990-2002 | 23 | 20 (87.0) | 3 (13.0) | 45.0 (30-66) | 23 (100) |
Tison et al[39] 2007 | 1983-2001 | 9 | 8 (88.9) | 1 (11.1) | 48.0 (37-63) | 8 (88.9) |
Rebours et al[40] 2007 | 1995-2004 | 105 | 96 (91.4) | 9 (8.6) | 46.0 (24-75) | 86 (81.9) |
Rahman et al[46] 2007 | 2000-2005 | 11 | 10 (90.9) | 1 (9.1) | 48.0 (35-61) | 10 (90.9) |
Castell-Monsalve et al[47] 2008 | NR | 5 | 4 (80.0) | 1 (20.0) | 47.0 (40-53) | 4 (80.0) |
Jovanovic et al[52] 2008 | 1996-2006 | 13 | 10 (76.9) | 3 (23.1) | 41.5 (17-60) | 6 (6.2) |
Casetti et al[63] 2009 | 1990-2006 | 58 | 54 (93.1) | 4 (6.9) | 44.7 (IQR 36.8-51.8) | 57 (98.3) |
Ishigami et al[6] 2010 | 2001-2008 | 15 | 14 (93.3) | 1 (6.7) | 48.0 (31-64) | NR |
Overall | - | 348 | 319 (91.70) | 29 (8.30) | - | 246/305 (80.70) |
Table 2 Epidemiological and clinical characteristics of patients in the 18 retrospective studies involving patients with a benign cystic duodenal wall (continues from Table 1) n (%)
Author[Ref.] yr | Time interval from the symptoms to the diagnosis | Abdominal pain | Weight loss | Jaundice | Hyperamylasemia | |
Mean (range) | No. of cases | Type | ||||
Stolte et al[7] 1982 | NR | NR | NR | 30 (100) | NR | NR |
Yamaguchi et al[10] 1992 | NR | 3 (37.5) | NR | 0 | 2 (25.0) | NR |
Fléjou et al[11] 1993 | NR | 7 (70.0) | Persistent | 9 (90.0) | 4 (40.0) | NR |
Itoh et al[12] 1994 | NR | 3 (75.0) | NR | NR | NR | 3 (75.0) |
Fékété et al[13] 1996 | NR | 6 (100) | Recurrent | 6 (100) | 0 | 6 (100) |
Procacci et al[16] 1997 | 4.5 yr (1-9) | 10 (100) | Recurrent | 4 (40.0) | 1 (10.0) | NR |
Irie et al[18] 1998 | NR | 4 (80.0) | NR | 0 | 0 | NR |
Vullierme et al[23] 2000 | 41.5 d (1-140) | NR | NR | NR | NR | NR |
Aoun et al[81] 2005 | NR | 3 (75.0) | NR | 0 | 1 (25.0) | NR |
Pessaux et al[36] 2006 | NR | 9 (75.0) | Persistent in 4 (44.4) | 12 (100) | 2 (16.7) | NR |
Jouannaud et al[37] 2006 | NR | 22 (95.7) | NR | 16 (69.6) | 0 | NR |
Tison et al[39] 2007 | NR | 9 (100) | NR | 9 (100) | 2 (22.2) | NR |
Rebours et al[40] 2007 | 1 yr (0-24) | 91 (86.7) | Continuous in 35 (38.4); occasional in 56 (61.5) | 73 (69.6) | 13 (12.4) | NR |
Rahman et al[46] 2007 | NR | 11 (100) | Recurrent in 8 (72.7) | 10 (90.9) | 0 | 2 (18.2) |
Castell-Monsalve et al[47] 2008 | NR | 5 (100) | Persistent | NR | NR | 5 (100) |
Jovanovic et al[52] 2008 | 7.5 mo (0.5-36) | 12 (92.3) | NR | 4 (30.8) | 4 (30.8) | NR |
Casetti et al[63] 2009 | NR | 46 (79.3) | Persistent | NR | 3 (5.2) | NR |
Ishigami et al[6] 2010 | NR | NR | NR | NR | NR | NR |
Overall | - | 241/283 | - | 173/246 | 32/274 | 16/26 |
(85.20) | (70.30) | (11.70) | (61.50) |
Table 3 Epidemiological and clinical characteristics of patients in the 18 retrospective studies involving patients with a benign cystic duodenal wall (continues from Table 2) n (%)
Author[Ref.] yr | Imaging | Duodenal findings | CBD stenosis | Duodenal stenosis |
Stolte et al[7] 1982 | NR | Brunner hyperplasia in 25 | 15 (50.0) | NR |
Yamaguchi et al[10] 1992 | US, CT, ERCP, PTC | Edema and nodular appearance; Brunner hyperplasia | 4 (50.0) | 5 (62.5) |
Fléjou et al[11] 1993 | ERCP, EUS | Edema and congestion of the mucosa | 0 | 7 (70.0) |
Itoh et al[12] 1994 | CT | NR | NR | NR |
Fékété et al[13] 1996 | CT, ERCP, EUS | Edema and congestion of the mucosa | 0 | 5 (83.3) |
Procacci et al[16] 1997 | CT, ERCP, EUS | Inflammation in 8 | 2 (20.0) | 2 (20.0) |
Irie et al[18] 1998 | MRI | Brunner hyperplasia in 3 | 2 (40.0) | 3 (60.0) |
Vullierme et al[23] 2000 | CT | NR | 3 (15.0) | 20 (100) |
Aoun et al[81] 2005 | US, CT, ERCP, EUS | NR | 4 (100) | NR |
Pessaux et al[36] 2006 | US, EUS, CT, ERCP, MRI | NR | NR | NR |
Jouannaud et al[37] 2006 | EUS, CT | Inflammation in 3 | NR | 8 (34.8) |
Tison et al[39] 2007 | US, CT, MRI, angiography | Non specific inflammation in 9 | 5 (55.6) | 9 (100) |
Rebours et al[40] 2007 | CT, EUS | Brunner hyperplasia in 61 | 26 (24.8) | 50 (47.6) |
Rahman et al[46] 2007 | CT, MRI, EUS | Brunner hyperplasia | 0 | 5 (45.5) |
Castell-Monsalve et al[47] 2008 | MRI, EUS | Duodenal stenosis in 3 | 3 (60.0) | 3 (60.0) |
Jovanovic et al[52] 2008 | US, CT, MRI, EUS | NR | 6 (46.2) | NR |
Casetti et al[63] 2009 | US, CT, MRI, EUS | NR | 3 (5.2) | NR |
Ishigami et al[6] 2010 | CT, MRI | NR | 9 (60.0) | NR |
Overall | - | - | 82/309 | 117/212 |
(26.50) | (55.20) |
Table 4 Epidemiological and clinical characteristics of patients in the 18 retrospective studies involving patients with a benign cystic duodenal wall (continues from Table 3) n (%)
Author[Ref.] yr | Surgery | Associated chronic pancreatitis | Associated neoplasms | Pseudocyst | Follow-up | |||
No. of cases | Type | Mean (range) | Death | Lost | ||||
Stolte et al[7] 1982 | 30 (100) | PD | 4 (13.3) (all with calcification) | No | 5 (16.7) | NR | NR | NR |
Yamaguchi et al[10] 1992 | 8 (100) | PD | NR | No | No | 2 yr | 1 (12.5) | NR |
Fléjou et al[11] 1993 | 10 (100) | WP in 8; | 0 | No | No | 1-5 yr | 1 (10.0) | 4 (40.0) |
derivative in 2 | ||||||||
Itoh et al[12] 1994 | 3 (75.0) | PD | NR | No | No | No | NR | NR |
Fékété et al[13] 1996 | 6 (100) | PD in 5; | NR | No | No | 32 mo (18-64) | No | NR |
antrectomy in 1 | ||||||||
Procacci et al[16] 1997 | 10 (100) | PD | 7 (70.0) (calcifications in 5) | No | 5 (head) (50.0) | NR | NR | NR |
Irie et al[18] 1998 | 3 (60.0) | PD | 2 (40.0) (all with calcifications) | No | No | NR | NR | NR |
Vullierme et al[23] 2000 | 20 (100) | PD | 9 (45.0)(calcifications in 5) | No | No | NR | NR | NR |
Aoun et al[81] 2005 | 4 (100) | PD | NR | NR | NR | NR | NR | NR |
Pessaux et al[36] 2006 | 12 (100) | PD | 8 (66.7) (calcification in 2) | No | No | 64 mo (6-158) | 1 (8.3) | 1 (8.3) |
Jouannaud et al[37] 2006 | 14 (60.9) | PD in 11; | 17 (73.9) (calcification in 10) | No | No | 47 mo | 1 (4.3) | NR |
derivative in 3 | ||||||||
Tison et al[39] 2007 | 9 (100) | PD | 5 (55.6) | No | No | 72 mo | 4 (44.4) | NR |
Rebours et al[40] 2007 | 29 (27.6) | PD in 17; digestive and biliary by pass in 12 | 97 (92.4) (calcification in 96) | No | No | 15 mo (0-243) | NR | NR |
Rahman et al[46] 2007 | 11 (100) | PD | 0 | No | No | NR | NR | NR |
Castell-Monsalve et al[47] 2008 | 4 (80.0) | WP in 3; | 3 (60.0) | No | No | NR (13-36 mo) | No | NR |
1 laparotomy | ||||||||
Jovanovic et al[52] 2008 | 13 (100) | PD | 6 (46.2) | No | No | NR | NR | NR |
Casetti et al[63] 2009 | 58 (100) | PD | NR | Neuroendocrine in 1 | No | 93.6 mo | NR | NR |
(IQR 59.7-129.7) | ||||||||
Ishigami et al[6] 2010 | 6 (40.0) | PD in 3, derivative surgery in 3 | NR | NR | NR | NR | NR | NR |
Overall | 250/348 | - | 158/253 | 1/329 | 10/329 | - | 8/73 | 5/22 |
(71.8) | (62.5) | (0.3%) | (3.0) | (11.0) | (22.7) |
Table 5 Epidemiological and clinical characteristics of patients in the 38 case report papers involving 46 subjects with a benign cystic duodenal wall (a paper may report more than one patient), the three cases reported in the present paper are also shown
Author[Ref.] yr | Gender | Age (yr) | Alcohol drinker |
Bill et al[74] 1982 | Male | 64 | Yes |
Holstege et al[75] 1985 | Male | 44 | Yes |
Tio et al[9] 1991 | Male | 48 | NR |
Tio et al[9] 1991 | Male | 53 | NR |
Flaherty et al[75] 1992 | Female | 20 mo | No |
Izbicki et al[77] 1994 | Male | 25 | NR |
Fujita et al[14] 1997 | Male | 42 | Yes |
Shudo et al[17] 1998 | Male | 66 | Yes |
Wu et al[78] 1998 | Male | 39 | NR |
Babál et al[79] 1998 | Female | 70 | NR |
Rubay et al[21] 1999 | Male | 46 | Yes |
Balachandar et al[22] 1999 | Male | 18 | NR |
Mohl et al[25] 2001 | Male | 44 | Yes |
Mohl et al[25] 2001 | Male | 42 | Yes |
Munthali Lovemore et al[26] 2001 | Male | 24 | No |
Indinnimeo et al [27] 2001 | Male | 46 | Yes |
Shudo et al[28] 2002 | Male | 53 | Yes |
Glaser et al[29] 2002 | Male | 51 | Yes |
Hwang et al[31] 2003 | Male | 46 | Yes |
Jovanovic et al[32] 2004 | Male | 38 | No |
McFaul et al[80] 2004 | Male | 29 | Yes |
McFaul et al[80] 2004 | Male | 62 | Yes |
Isayama et al[33] 2005 | Male | 56 | Yes |
Chatelain et al[34] 2005 | Male | 47 | Yes |
Chatelain et al[34] 2005 | Female | 44 | Yes |
Balzan et al[35] 2005 | Male | 47 | NR |
Sanada et al[43] 2007 | Male | 81 | No |
Balakrishnan et al[44] 2007 | Male | 40 | Yes |
de Tejada et al[50] 2008 | Male | 47 | Yes |
Stefanescu et al[51] 2008 | Male | 15 | No |
Varma et al[53] 2008 | Female | 23 | NR |
Galloro et al[54] 2008 | Male | 44 | Yes |
Thomas et al[59] 2009 | Male | 43 | NR |
Levenick et al[61] 2009 | Female | 35 | Yes |
Levenick et al[61] 2009 | Male | 47 | Yes |
Levenick et al[61] 2009 | Female | 36 | Yes |
Levenick et al[61] 2009 | Female | 54 | NR |
Yoshida et al[62] 2009 | Male | 63 | Yes |
Meesiri[64] 2009 | Male | 44 | Yes |
Funamizu et al[65] 2009 | Female | 54 | NR |
Viñolo Ubiña et al[66] 2010 | Male | 40 | Yes |
Tezuka et al[67] 2010 | Male | 55 | Yes |
Lee et al[69] 2010 | Male | 75 | NR |
Egorov et al[70] 2010 | Male | 32 | Yes |
Egorov et al[70] 2010 | Male | 43 | NR |
German et al[72] 2010 | Male | 34 | Yes |
Pezzilli2011 Present paper | Female | 65 | No |
Pezzilli 2011 Present paper | Male | 49 | Yes |
Pezzilli 2011 Present paper | Male | 56 | No |
Overall | Males: 40 (81.6%) | 45.3 ± 15.2 | 29/36 |
Females: 9 (18.4%) | (80.50%) |
Table 6 Epidemiological and clinical characteristics of patients in the 38 case report papers involving 46 subjects with a benign cystic duodenal wall (a paper may report more than one patient), the three cases reported in the present paper are also shown (continues from Table 5)
Author[Ref.] yr | Time interval from the onset of symptoms to diagnosis | Abdominal pain | Weight loss | Jaundice | Hyperamylasemia |
Bill et al[74] 1982 | NR | Yes (Persistent) | Yes | No | No |
Holstege et al[75] 1985 | 6 mo | Yes (Persistent) | Yes | No | Yes |
Tio et al[9] 1991 | NR | Yes (NR) | No | No | NR |
Tio et al[9] 1991 | NR | Yes (NR) | No | Yes | NR |
Flaherty et al[75] 1992 | NR | Yes (NR) | No | No | NR |
Izbicki et al[77] 1994 | NR | Yes (Recurrent) | No | No | No |
Fujita et al[14] 1997 | NR | Yes (Recurrent) | Yes | No | No |
Shudo et al[17] 1998 | NR | Yes (Persistent) | No | No | Yes |
Wu et al[78] 1998 | 10 yr | Yes (Recurrent) | Yes | No | NR |
Babál et al[79] 1998 | NR | No | No | No | NR |
Rubay et al[21] 1999 | 7 yr | Yes (Recurrent) | Yes | No | Yes |
Balachandar et al[22] 1999 | NR | No | No | Yes | No |
Mohl et al[25] 2001 | 1 yr | Yes (Recurrent) | Yes | No | NR |
Mohl et al[25] 2001 | 1 yr | Yes (Persistent) | Yes | No | NR |
Munthali Lovemore et al[26] 2001 | NR | Yes (Persistent) | NR | Yes | Yes |
Indinnimeo et al[27] 2001 | 10 yr | Yes (Recurrent) | No | No | Yes |
Shudo et al[28] 2002 | NR | Yes (Persistent) | No | No | Yes |
Glaser et al[29] 2002 | NR | Yes (Persistent) | Yes | No | No |
Hwang et al[31] 2003 | NR | Yes (Persistent) | Yes | No | Yes |
Jovanovic et al[32] 2004 | NR | Yes (Persistent) | Yes | No | Yes |
McFaul et al[80] 2004 | 13 mo | Yes (Recurrent) | Yes | No | NR |
McFaul et al[80] 2004 | 2 yr | Yes (Recurrent) | Yes | Yes | NR |
Isayama et al[33] 2005 | 2 yr | Yes (Persistent) | Yes | No | No |
Chatelain et al[34] 2005 | 1 yr | Yes (Recurrent) | Yes | No | No |
Chatelain et al[34] 2005 | NR | Yes (Persistent) | Yes | No | No |
Balzan et al[35] 2005 | 2 yr | Yes (Persistent) | No | No | Yes |
Sanada et al[43] 2007 | NR | Yes (Persistent) | No | No | Yes |
Balakrishnan et al[44] 2007 | NR | Yes (Persistent) | Yes | No | Yes |
de Tejada et al[50] 2008 | 2 mo | Yes (Persistent) | Yes | No | NR |
Stefanescu et al[51] 2008 | 5 mo | Yes (Persistent) | Yes | No | NR |
Varma et al[53] 2008 | 3 mo | Yes (Persistent) | Yes | No | NR |
Galloro et al[54] 2008 | NR | Yes (Recurrent) | Yes | No | Yes |
Thomas et al[59] 2009 | NR | Yes (NR) | Yes | No | NR |
Levenick et al[61] 2009 | NR | Yes (Recurrent) | NR | No | NR |
Levenick et al[61] 2009 | NR | Yes (Recurrent) | Yes | No | NR |
Levenick et al[61] 2009 | NR | Yes (Recurrent) | Yes | No | NR |
Levenick et al[61] 2009 | NR | No | Yes | No | NR |
Yoshida et al[62] 2009 | NR | Yes (Persistent) | No | No | Yes |
Meesiri[64] 2009 | NR | Yes (Recurrent) | No | No | Yes |
Funamizu et al[65] 2009 | NR | Yes (Persistent) | No | Yes | Yes |
Viñolo Ubiña et al[66] 2010 | 3 mo | Yes (Persistent) | No | No | Yes |
Tezuka et al[67] 2010 | NR | Yes (NR) | No | No | Yes |
Lee et al[69] 2010 | NR | Yes (Recurrent) | No | No | Yes |
Egorov et al[70] 2010 | 2 mo | Yes (Persistent) | Yes | No | Yes |
Egorov et al[70] 2010 | 1 yr | Yes (Persistent) | Yes | Yes | No |
German et al[72] 2010 | NR | Yes (Recurrent) | Yes | No | Yes |
Pezzilli 2011 Present paper | 1 yr | Yes (Recurrent) | Yes | Yes | No |
Pezzilli 2011 Present paper | 7 mo | Yes (Persistent) | Yes | No | Yes |
Pezzilli 2011 Present paper | 1 mo | Yes (Persistent) | Yes | Yes | Yes |
Overall | 2.1 ± 3.1 yr | 46/49 | 30/47 | 8/49 | 22/33 |
(93.90%) | (63.80%) | (16.30%) | (66.70%) |
Table 7 Epidemiological and clinical characteristics of patients in the 38 case report papers involving 46 subjects with a benign cystic duodenal wall (a paper may report more than one patient), the three cases reported in the present paper are also shown (continues from Table 6)
Author[Ref.] yr | Imaging | Duodenal findings | CBD stenosis | Duodenal stenosis |
Bill et al[74] 1982 | US, ERCP, angiography | NR | Yes | No |
Holstege et al[75] 1985 | US, CT, ERCP | Severe erosive gastritis + bulging of the duodenum | No | Yes |
Tio et al[9] 1991 | ERCP, EUS, US | Polypoid lesion | Yes | Yes |
Tio et al[9] 1991 | ERCP, EUS, US | NR | No | Yes |
Flaherty et al[75] 1992 | US | No | No | No |
Izbicki et al[77] 1994 | US, angiography, ERCP | NR | Yes | Yes |
Fujita et al[14] 1997 | US, CT, ERCP | Inflammation | No | Yes |
Shudo et al[17] 1998 | CT, US, ERCP, EUS, celiac angiography | Edema duodenal wall, Brunner hyperplasia | No | Yes |
Wu et al[78] 1998 | CT | NR | No | No |
Babál et al[79] 1998 | NR | NR | No | No |
Rubay et al[21] 1999 | CT, ERCP, MRI, EUS | No alterations | NR | Yes |
Balachandar et al[22] 1999 | CT, ERCP | No duodenal alteration | Yes | No |
Mohl et al[25] 2001 | CT | Stenosis | No | Yes |
Mohl et al[25] 2001 | US, CT, ERCP | Normal duodenal mucosa | No | No |
Munthali Lovemore et al[26] 2001 | US, CT, ERCP | NR | Yes | No |
Indinnimeo et al[27] 2001 | CT, MRI, EUS | No alterations | No | No |
Shudo et al[28] 2002 | CT, US, ERCP, EUS, celiac angiography | Irregular polypoid bulging; inflammation of the mucosa | NR | Yes |
Glaser et al[29] 2002 | US | Severe deformation + inflammatory changes | No | Yes |
Hwang et al[31] 2003 | US, CT, MRI | Duodenal inflammation, duodenal stenosis | NR | Yes |
Jovanovic et al[32] 2004 | US, CT, EUS, MRI | Stenosis | No | Yes |
McFaul et al[80] 2004 | US, CT, MRI | Brunner hyperplasia | Yes | Yes |
McFaul et al[80] 2004 | US, PET-CT | Brunner hyperplasia | No | No |
Isayama et al[33] 2005 | CT, EUS, MRCP, ERCP | NR | No | Yes |
Chatelain et al[34] 2005 | EUS, CT | Duodenal stenosis, inflammation | No | Yes |
Chatelain et al[34] 2005 | EUS, CT | Duodenal stenosis | No | Yes |
Balzan et al[35] 2005 | US, MRI, CT | NR | NR | NR |
Sanada et al[43] 2007 | CT, ERCP | Edema duodenal wall, Brunner hyperplasia | Yes | No |
Balakrishnan et al[44] 2007 | CT, ERCP, EUS | Edematous, shiny, reddish raise mucosa with polypoid appearance; Brunner hyperplasia | No | No |
de Tejada et al[50] 2008 | MRI, EUS | Bulging, Brunner hyperplasia | No | No |
Stefanescu et al[51] 2008 | CT, EUS | NR | No | Yes |
Varma et al[53] 2008 | US, CT | Brunner hyperplasia | No | No |
Galloro et al[54] 2008 | US, CT, EUS | Duodenal stenosis | No | Yes |
Thomas et al[59] 2009 | US, CT, EUS, octreotide scan | Brunner hyperplasia | No | Yes |
Levenick et al[61] 2009 | EUS, MRCP | Duodenal stenosis | No | Yes |
Levenick et al[61] 2009 | CT, EUS | Duodenal inflammation, duodenal stenosis | NR | Yes |
Levenick et al[61] 2009 | CT, EUS | Edema with acute and chronic inflammation | No | Yes |
Levenick et al[61] 2009 | CT, EUS, ERCP | NR | Yes | No |
Yoshida et al[62] 2009 | CT, MRCP | Normal mucosa | No | Yes |
Meesiri[64] 2009 | US, CT, MRI | Edema and hemorrhagic mucosa with inflammation | NR | No |
Funamizu et al[65] 2009 | ERCP, CT, angiography | NR | Yes | No |
Viñolo Ubiñaet al[66] 2010 | CT | Stenosis | NR | Yes |
Tezuka et al[67] 2010 | CT, ERCP | Edema duodenal wall | No | Yes |
Lee et al[69] 2010 | CT, MRCP | Active ulcer | Yes | No |
Egorov et al[70] 2010 | US, CT, EUS | Deformation, infiltration and ulcer; Inflammation | No | Yes |
Egorov et al[70] 2010 | US, CT, MRI, EUS | NR | Yes | Yes |
German et al[72] 2010 | US, CT, MRI | Edema duodenal wall; Brunner hyperplasia | Yes | Yes |
Pezzilli 2011 Present paper | US, CT, EUS, ERCP | No | Yes | No |
Pezzilli 2011 Present paper | US, CT, MRI | Hypertrophy of the Brunner glands | No | No |
Pezzilli 2011 Present paper | US, CT | No | Yes | No |
Overall | - | - | 14/42 | 28/48 |
(33.30%) | (58.30%) |
Table 8 Epidemiological and clinical characteristics of patients in the 38 case report papers involving 46 subjects with a benign cystic duodenal wall (a paper may report more than one patient), The three cases reported in the present paper are also shown (continues from Table 7)
Author[Ref.] yr | Surgery | Type of surgery | Endoscopic treatment | Associated chronic pancreatitis | Associated neoplasms | Pseudocyst | Follow-up | Death |
Bill et al[74] 1982 | Yes | PD | No | NR | No | No | No | NR |
Holstege et al[75] 1985 | Yes | WP | No | No | No | No | No | NR |
Tio et al[9] 1991 | No | No | No | No | No | 7 yr | No | |
Tio et al[9] 1991 | Yes | Derivative surgery | No | No | No | No | 6 mo | NR |
Flaherty et al[75] 1992 | Yes | PD | No | No | No | No | 9 mo | No |
Izbicki et al[77] 1994 | Yes | PD | No | No | No | No | 6 yr | No |
Fujita et al[14] 1997 | Yes | PD | No | No | No | No | 3 yr | No |
Shudo et al[17] 1998 | Yes | PD | No | No | No | No | NR | NR |
Wu et al[78] 1998 | Yes | WP | No | No | No | No | 9 mo | No |
Babál et al[79] 1998 | No | No | No | No | No | NR | During hospitalization | |
Rubay et al[21] 1999 | Yes | PD | No | No | No | No | 2 mo | No |
Balachandar et al[22] 1999 | Yes | Derivative | No | Yes | No | No | NR | NR |
Mohl et al[25] 2001 | Yes | PD | No | No | No | No | No | NR |
Mohl et al[25] 2001 | Yes | PD | No | No | No | No | 4 wk after surgery | No |
Munthali Lovemore et al[26] 2001 | Yes | Derivative CBD | No | No | No | No | No | NR |
Indinnimeo et al[27] 2001 | Yes | PD | No | No | No | No | 2 yr | No |
Shudo et al[28] 2002 | Yes | PD | No | No | No | No | NR | NR |
Glaser et al[29] 2002 | No | No | No | No | No | No | NR | |
Hwang et al[31] 2003 | No | No | No | No | No | NR | NR | |
Jovanovic et al[32] 2004 | Yes | PD | No | No | No | No | No | NR |
McFaul et al[80] 2004 | Yes | PD | No | Yes | No | No | 2 yr | No |
McFaul et al[80] 2004 | Yes | WP | No | Yes | No | No | NR | No |
Isayama et al[33] 2005 | No | Yes | No | No | No | 12 mo | No | |
Chatelain et al[34] 2005 | Yes | PD | No | No | No | No | 6 mo | No |
Chatelain et al[34] 2005 | Yes | PD | No | No | No | No | 12 mo | No |
Balzan et al[35] 2005 | Yes | PD | No | Yes | No | Yes (head) | No | NR |
Sanada et al[43] 2007 | Yes | PD | No | No | No | Yes (head) | No | NR |
Balakrishnan et al[44] 2007 | Yes | Laparotomy | No | Yes | No | No | NR | NR |
de Tejada et al[50] 2008 | Yes | WP | No | No | No | No | 3 mo | No |
Stefanescu et al[51] 2008 | Yes | Derivative | No | No | No | No | 8 mo | No |
Varma et al[53] 2008 | Yes | WP | No | No | No | No | 9 mo | No |
Galloro et al[54] 2008 | Yes | WP | No | Yes | Cystadenoma | Yes | 14 mo | No |
(with calcifications) | ||||||||
Thomas et al[59] 2009 | Yes | PD | No | No | No | No | NR | NR |
Levenick et al[61] 2009 | Yes | PD | No | No | No | No | 3 yr | No |
Levenick et al[61] 2009 | Yes | PD | No | Yes | No | No | NR | NR |
Levenick et al[61] 2009 | Yes | PD | No | No | No | No | NR | NR |
Levenick et al[61] 2009 | Yes | PD | No | No | No | No | NR | NR |
Yoshida et al[62] 2009 | Yes | PD | No | No | No | No | Yes (time NR) | No |
Meesiri[64] 2009 | No | No | No | No | No | Yes (time NR) | No | |
Funamizu et al[65] 2009 | Yes | PD | No | No | Yes | No | 15 mo | No |
Viñolo Ubiña et al[66] 2010 | Yes | PD | No | No | No | No | NR | No |
Tezuka et al[67] 2010 | Yes | PD | No | No | No | No | NR | No |
Lee et al[69] 2010 | No | No | No | No | No | NR | NR | |
Egorov et al[70] 2010 | Yes | Pancreas-preserving duodenal resection | No | No | No | No | 6 mo | No |
Egorov et al[70] 2010 | Yes | Pancreas-preserving duodenal resection | No | No | No | No | 5 mo | No |
German et al[72] 2010 | Yes | PD | No | No | No | No | 2 mo | NR |
Pezzilli 2011 Present paper | No | Yes | No | No | No | 20 mo | No | |
Pezzilli 2011 Present paper | Yes | PD | No | No | No | No | 7 mo | No |
Pezzilli 2011 Present paper | Yes | PD | No | Autoimmune pancreatitis | Yes | No | 4 mo | No |
Overall | 41/49 | - | 2/49 | 8/48 | 3/49 | 3/49 | 17.9 ± 20.6 mo | 1/28 |
(83.70%) | (4.10%) | (16.70%) | (6.10%) | (6.10%) | (3.60%) |
Table 9 Epidemiological and clinical characteristics of patients in the two retrospective studies and two case report papers involving two subjects with groove adenocarcinoma
Author[Ref.] yr | Type of study | Time interval of patient enrollment | No. of patients | Age (yr) | Alcohol drinkers | ||
Total | Males | Females | Mean (range) | ||||
Suehara et al[20] 1998 | Case report | 1995 | 1 | 1 | - | 61 | Yes |
Gabata et al[30] 2003 | Retrospective | 1998-2001 | 9 | 4 (44.4%) | 5 (55.6%) | 72 (56-87) | NR |
Tan et al[38] 2006 | Case report | NR | 1 | - | 1 | 69 | NR |
Ishigami et al[6] 2010 | Retrospective | 2001-2008 | 7 | 6 (85.7%) | 1 (14.3%) | 70 (57-80) | NR |
Table 10 Epidemiological and clinical characteristics of patients in the two retrospective studies and two case report papers involving two subjects with groove adenocarcinoma (continues from Table 9)
Table 11 Epidemiological and clinical characteristics of patients in the two retrospective studies and two case report papers involving two subjects with groove adenocarcinoma (continues from Table 10)
Table 12 Epidemiological and clinical characteristics of patients in the two retrospective studies and two case report papers involving two subjects with groove adenocarcinoma (continues from Table 11)
- Citation: Pezzilli R, Santini D, Calculli L, Casadei R, Morselli-Labate AM, Imbrogno A, Fabbri D, Taffurelli G, Ricci C, Corinaldesi R. Cystic dystrophy of the duodenal wall is not always associated with chronic pancreatitis. World J Gastroenterol 2011; 17(39): 4349-4364
- URL: https://www.wjgnet.com/1007-9327/full/v17/i39/4349.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i39.4349